1. Aragão GF, Brandão CB, Júnior JEL. Cannabidiol in autism: Clinical pharmacology priorities for trial design. Br J Clin Pharmacol.…
1. Correction to « Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder ». Clin Pharmacol…
1. Sonn JY, Kim W, Iwanaszko M, Aoi Y, Li Y, Qi G, Parkitny L, Brissette JL, Weiner L, Botas…
1. Al-Bustanji R, AlRababah BK, Rumman MSA, Abukhaled Y, Al-Rabadi N, Younis HKB, Ghalyon G, Al-Tawalbeh S, Aloudat O, Alrashdan…
1. Boer J, Boonstra N, Kronenberg L, Kuipers S, Vuijk R, Sizoo B. Autistic eye contact? A hermeneutic phenomenological multicenter…
1. Kim T, Lee J, Lee J, Jo H, Oh Y, Kim YJ, Seo J. Sensory abnormalities in autism spectrum…
1. Aivazidis A, Memi F, Rademaker K, Koko M, Roberts K, Trinh A, Petryszak R, Kleshchevnikov V, Tuck L, Lisgo…
1. Chang C, Carandang RR, Silverberg J, Surkis C, Cunningham SD, Wang K, Qasba N. Patient Experiences in Accessing Reproductive…
1. Aldakhil AF, Alasim KN. Diagnostic accuracy of AI-based models for autism spectrum disorder: A systematic review and meta-analysis with…
© 2026 Copyright Centre de Ressources Autisme Rhône-Alpes – CRA Rhône-Alpes - Mentions Légales .
